Mayra A. Borrero Landazabal

Mayra A. Borrero Landazabal

Auto-generated profile, based on publicly available information

Mayra A. Borrero Landazabal

IMol Polish Academy of Sciences, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 March 2024 in Journal of Cell Biology
Verified
Journal Article
Open access
PDF file
MKMagda Krakowczyk
Magda Krakowczyk
ALAnna M. Lenkiewicz
Anna M. Lenkiewicz
TSTomasz Sitarz
Tomasz Sitarz
DMDominika Malińska
Dominika Malińska
MBMayra Borrero
Mayra Borrero
PBPiotr Brągoszewski
Piotr Brągoszewski
Most mitochondrial proteins originate from the cytosol and require transport into the organelle. Such precursor proteins must be unfolded to pass through translocation channels in mitochondrial membranes. Misfolding of transported proteins can result in their arrest and translocation failure. Arrested proteins block further import, disturbing mitochondrial functions and cellular proteostasis. Cellular responses to translocation failure have been defined in yeast. We developed the cell line-based translocase clogging model to discover molecular mechanisms that resolve failed import events in humans. The mechanism we uncover differs significantly from these described in fungi, where ATPase-driven extraction of blocked protein is directly coupled with proteasomal processing. We found human cells to rely primarily on mitochondrial factors to clear translocation channel blockage. The mitochondrial membrane depolarization triggered proteolytic cleavage of the stalled protein, which involved mitochondrial protease OMA1. The cleavage allowed releasing the protein fragment that blocked the translocase. The released fragment was further cleared in the cytosol by VCP/p97 and the proteasome.

1 January 2018 in Pesticide Biochemistry and Physiology
Verified
Journal Article
Closed access
MLMayra A. Borrero Landazabal
Mayra A. Borrero Landazabal
AOAurora L. Carreño Otero
Aurora L. Carreño Otero
VKVladimir V. Kouznetsov
Vladimir V. Kouznetsov
JDJonny Edward Duque
Jonny Edward Duque
SMStelia Mendez
Stelia Mendez

1 March 2020 in Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology
Verified
Journal Article
Closed access
MBMayra A. Borrero-Landazabal
Mayra A. Borrero-Landazabal
JDJonny Edward Duque
Jonny Edward Duque
SMStelia Mendez
Stelia Mendez

7 March 2025 in EMBO Reports
Verified
Journal Article
Open access
BMBen Hur Marins Mussulini
Ben Hur Marins Mussulini
KMKlaudia K Maruszczak
Klaudia K Maruszczak
PDPiotr Draczkowski
Piotr Draczkowski
MBMayra A Borrero-Landazabal
Mayra A Borrero-Landazabal
Selvaraj AyyamperumalSelvaraj Ayyamperumal
Selvaraj Ayyamperumal
Agnieszka ChacinskaAgnieszka Chacinska
Agnieszka Chacinska
Mitochondria harbor respiratory complexes that perform oxidative phosphorylation. Complex I is the first enzyme of the respiratory chain that oxidizes NADH. A dysfunction in complex I can result in higher cellular levels of NADH, which in turn strengthens the interaction between apoptosis-inducing factor 1 (AIFM1) and Mitochondrial intermembrane space import and assembly protein 40 (MIA40) in the mitochondrial intermembrane space. We investigated whether MIA40 modulates the activity of AIFM1 upon increased NADH/NAD+ balance. We found that in model cells characterized by an increase in NADH the AIFM1-MIA40 interaction is strengthened and these cells demonstrate resistance to AIFM1-induced cell death. Either silencing of MIA40, rescue of complex I, or depletion of NADH through the expression of yeast NADH-ubiquinone oxidoreductase-2 sensitized NDUFA13-KO cells to AIFM1-induced cell death. These findings indicate that the complex of MIA40 and AIFM1 suppresses AIFM1-induced cell death in a NADH-dependent manner. This study identifies an effector complex involved in regulating the programmed cell death that accommodates the metabolic changes in the cell and provides a molecular explanation for AIFM1-mediated chemoresistance of cancer cells.

1 May 2026 in Science Advances
Verified
Journal Article
Open access
MBMayra A. Borrero-Landazabal
Mayra A. Borrero-Landazabal
VLVanessa Linke
Vanessa Linke
TKTereza Kadavá
Tereza Kadavá
ZLZeshi Li
Zeshi Li
PDPiotr Draczkowski
Piotr Draczkowski
Agnieszka ChacinskaAgnieszka Chacinska
Agnieszka Chacinska
The translocase of the outer mitochondrial membrane (TOM) is the conserved entry gate for nuclear-encoded proteins. While structurally similar from yeast to humans, the human TOM complex operates in a cellular environment of vastly greater complexity. Here, we present a high-confidence map of the human TOM interactome using a membrane-permeable cross-linker to capture both stable and transient interactors. Alongside extensive overlap with known yeast partners, we uncover a set of human-specific interactors including regulatory factors and TOM-associated proteins. Mapping unique interprotein cross-links reveals conformational flexibility of the receptor TOM20 and enhanced recovery of peripheral components such as TOM70 and several associated quality control factors. Notably, we identify FKBP8 (FK506 binding protein 8) as a human-specific interactor that binds multiple TOM subunits and promotes organization of the complex. Our work redefines the human TOM complex as a dynamic, multifaceted hub coordinating biogenesis, quality control, and signaling. This expanded TOM landscape offers a rich resource for exploring mitochondrial regulation in health and disease.